Osama M. El‐Badry

636 total citations
9 papers, 533 citations indexed

About

Osama M. El‐Badry is a scholar working on Organic Chemistry, Molecular Biology and Neurology. According to data from OpenAlex, Osama M. El‐Badry has authored 9 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Osama M. El‐Badry's work include Synthesis and biological activity (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Neuroblastoma Research and Treatments (3 papers). Osama M. El‐Badry is often cited by papers focused on Synthesis and biological activity (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers) and Neuroblastoma Research and Treatments (3 papers). Osama M. El‐Badry collaborates with scholars based in United States and Egypt. Osama M. El‐Badry's co-authors include Lee J. Helman, Mark A. Israel, Caterina P. Minniti, Elise C. Kohn, Peter J. Houghton, William H. Daughaday, Mark J. Cooper, Joyce A. Romanus, Matthew M. Rechler and A. Evans and has published in prestigious journals such as Journal of Clinical Investigation, Current Pharmaceutical Design and Bioorganic Chemistry.

In The Last Decade

Osama M. El‐Badry

9 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Osama M. El‐Badry United States 5 289 196 145 138 107 9 533
Thomas Strömberg Sweden 12 503 1.7× 168 0.9× 49 0.3× 151 1.1× 34 0.3× 15 744
Francine Hébert United States 15 185 0.6× 240 1.2× 97 0.7× 89 0.6× 118 1.1× 18 632
Antonio C. Fuentes-Fayos Spain 14 335 1.2× 109 0.6× 59 0.4× 163 1.2× 79 0.7× 34 547
Marine Guillaud-Bataille France 15 365 1.3× 166 0.8× 101 0.7× 254 1.8× 183 1.7× 27 781
Maria Chiara Anania Italy 12 258 0.9× 90 0.5× 51 0.4× 108 0.8× 175 1.6× 15 558
Chris J. McCabe United Kingdom 10 288 1.0× 360 1.8× 58 0.4× 129 0.9× 26 0.2× 13 673
Jung Hun Song South Korea 10 384 1.3× 321 1.6× 26 0.2× 92 0.7× 117 1.1× 10 757
Samantha Gadd United States 16 485 1.7× 91 0.5× 47 0.3× 94 0.7× 168 1.6× 24 741
Alexandre Arcaro Switzerland 14 393 1.4× 53 0.3× 49 0.3× 209 1.5× 80 0.7× 20 606
Magdalena Chmara Poland 12 294 1.0× 43 0.2× 183 1.3× 73 0.5× 97 0.9× 32 679

Countries citing papers authored by Osama M. El‐Badry

Since Specialization
Citations

This map shows the geographic impact of Osama M. El‐Badry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Osama M. El‐Badry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Osama M. El‐Badry more than expected).

Fields of papers citing papers by Osama M. El‐Badry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Osama M. El‐Badry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Osama M. El‐Badry. The network helps show where Osama M. El‐Badry may publish in the future.

Co-authorship network of co-authors of Osama M. El‐Badry

This figure shows the co-authorship network connecting the top 25 collaborators of Osama M. El‐Badry. A scholar is included among the top collaborators of Osama M. El‐Badry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Osama M. El‐Badry. Osama M. El‐Badry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
El‐Badry, Osama M., et al.. (2025). Pyrimidine: A Privileged Scaffold for the Development of Anticancer Agents as Protein Kinase Inhibitors (Recent Update). Current Pharmaceutical Design. 31(14). 1100–1129. 4 indexed citations
2.
El‐Badry, Osama M., et al.. (2024). Design, Synthesis, and Molecular Docking of Novel Miscellaneous Chalcones as p38α Mitogen‐Activated Protein Kinase Inhibitors. Chemistry & Biodiversity. 21(4). e202400077–e202400077. 12 indexed citations
3.
El‐Badry, Osama M., et al.. (2017). Design & synthesis of novel oxazolone & triazinone derivatives and their biological evaluation as COX-2 inhibitors. Bioorganic Chemistry. 72. 308–314. 19 indexed citations
4.
El‐Badry, Osama M. & Mark A. Israel. (1993). Growth regulation of human neuroblastoma. Cancer treatment and research. 63. 105–128. 2 indexed citations
5.
El‐Badry, Osama M., Lee J. Helman, Jane Chatten, et al.. (1991). Insulin-like growth factor II-mediated proliferation of human neuroblastoma.. Journal of Clinical Investigation. 87(2). 648–657. 114 indexed citations
6.
El‐Badry, Osama M., Caterina P. Minniti, Elise C. Kohn, et al.. (1990). Insulin-like growth factor II acts as an autocrine growth and motility factor in human rhabdomyosarcoma tumors.. PubMed. 1(7). 325–31. 213 indexed citations
7.
El‐Badry, Osama M., Joyce A. Romanus, Lee J. Helman, et al.. (1989). Autonomous growth of a human neuroblastoma cell line is mediated by insulin-like growth factor II.. Journal of Clinical Investigation. 84(3). 829–839. 163 indexed citations
8.
Biedler, June L., Osama M. El‐Badry, Marian B. Meyers, et al.. (1985). Growth stage-related synthesis and secretion of proteins by human neuroblastoma cells and their variants.. PubMed. 175. 209–21. 4 indexed citations
9.
El‐Badry, Osama M.. (1985). Pyridine and reduced pyridine analogs as histamine H2-receptor antagonists. University of Alberta Library. 20(5). 403–407. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Strömberg Breakdown of academic impact, for papers by Francine Hébert Breakdown of academic impact, for papers by Antonio C. Fuentes-Fayos Breakdown of academic impact, for papers by Marine Guillaud-Bataille Breakdown of academic impact, for papers by Maria Chiara Anania Breakdown of academic impact, for papers by Chris J. McCabe Breakdown of academic impact, for papers by Jung Hun Song Breakdown of academic impact, for papers by Samantha Gadd Breakdown of academic impact, for papers by Alexandre Arcaro Breakdown of academic impact, for papers by Magdalena Chmara
Rankless by CCL
2026